222 related articles for article (PubMed ID: 10346884)
21. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.
Yoshikawa T; Pardridge WM
J Pharmacol Exp Ther; 1992 Nov; 263(2):897-903. PubMed ID: 1432704
[TBL] [Abstract][Full Text] [Related]
22. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
[TBL] [Abstract][Full Text] [Related]
23. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery.
Pardridge WM; Kang YS; Buciak JL
Pharm Res; 1994 May; 11(5):738-46. PubMed ID: 8058646
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, radiolabeling, and preclinical evaluation of a new octreotide analog for somatostatin receptor-positive tumor scintigraphy.
De K; Bhowmik A; Behera A; Banerjee I; Ghosh MK; Misra M
J Pept Sci; 2012 Dec; 18(12):720-30. PubMed ID: 23109400
[TBL] [Abstract][Full Text] [Related]
25. Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector.
Song BW; Vinters HV; Wu D; Pardridge WM
J Pharmacol Exp Ther; 2002 May; 301(2):605-10. PubMed ID: 11961063
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic analysis and uptake of 18F-FBPA-Fr after ultrasound-induced blood-brain barrier disruption for potential enhancement of boron delivery for neutron capture therapy.
Yang FY; Chang WY; Li JJ; Wang HE; Chen JC; Chang CW
J Nucl Med; 2014 Apr; 55(4):616-21. PubMed ID: 24525207
[TBL] [Abstract][Full Text] [Related]
27. Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice.
Tolmachev V; Orlova A; Wei Q; Bruskin A; Carlsson J; Gedda L
Cancer Biother Radiopharm; 2004 Aug; 19(4):491-501. PubMed ID: 15453964
[TBL] [Abstract][Full Text] [Related]
28. Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors.
Yang W; Barth RF; Adams DM; Soloway AH
Cancer Res; 1997 Oct; 57(19):4333-9. PubMed ID: 9331095
[TBL] [Abstract][Full Text] [Related]
29. [177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma.
Sundberg AL; Gedda L; Orlova A; Bruskin A; Blomquist E; Carlsson J; Tolmachev V
Cancer Biother Radiopharm; 2004 Apr; 19(2):195-204. PubMed ID: 15186600
[TBL] [Abstract][Full Text] [Related]
30. Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors.
Shevtsov MA; Nikolaev BP; Yakovleva LY; Marchenko YY; Dobrodumov AV; Mikhrina AL; Martynova MG; Bystrova OA; Yakovenko IV; Ischenko AM
Int J Nanomedicine; 2014; 9():273-87. PubMed ID: 24421639
[TBL] [Abstract][Full Text] [Related]
31. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM
J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
[TBL] [Abstract][Full Text] [Related]
32. Stability of the disulfide bond in an avidin-biotin linked chimeric peptide during in vivo transcytosis through brain endothelial cells.
Kang YS; Voigt K; Bickel U
J Drug Target; 2000; 8(6):425-34. PubMed ID: 11328668
[TBL] [Abstract][Full Text] [Related]
33. OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma.
Yue PJ; He L; Qiu SW; Li Y; Liao YJ; Li XP; Xie D; Peng Y
Mol Cancer; 2014 Aug; 13():191. PubMed ID: 25128329
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical.
Wang S; Luo J; Lantrip DA; Waters DJ; Mathias CJ; Green MA; Fuchs PL; Low PS
Bioconjug Chem; 1997; 8(5):673-9. PubMed ID: 9327130
[TBL] [Abstract][Full Text] [Related]
35. Preferential labeling of glial and meningial brain tumors with [2-(14)C]acetate.
Dienel GA; Popp D; Drew PD; Ball K; Krisht A; Cruz NF
J Nucl Med; 2001 Aug; 42(8):1243-50. PubMed ID: 11483687
[TBL] [Abstract][Full Text] [Related]
36. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
Yang W; Barth RF; Wu G; Bandyopadhyaya AK; Thirumamagal BT; Tjarks W; Binns PJ; Riley K; Patel H; Coderre JA; Ciesielski MJ; Fenstermaker RA
Appl Radiat Isot; 2004 Nov; 61(5):981-5. PubMed ID: 15308179
[TBL] [Abstract][Full Text] [Related]
37. Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats.
Samnick S; Richter S; Romeike BF; Heimann A; Feiden W; Kempski O; Kirsch CM
Eur J Nucl Med; 2000 Oct; 27(10):1543-51. PubMed ID: 11083545
[TBL] [Abstract][Full Text] [Related]
38. Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin.
Zhang Y; Pardridge WM
Brain Res; 2001 Jan; 889(1-2):49-56. PubMed ID: 11166685
[TBL] [Abstract][Full Text] [Related]
39. EGF receptor targeted tumor imaging with biotin-PEG-EGF linked to (99m)Tc-HYNIC labeled avidin and streptavidin.
Jung KH; Park JW; Paik JY; Quach CH; Choe YS; Lee KH
Nucl Med Biol; 2012 Nov; 39(8):1122-7. PubMed ID: 22819251
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]